Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by westcoast1000

T.ONC

RE:RE:RE:RE:RE:AA and mBC

I am profuoundly sick of hearing this second guessing: ______ I agree that...

June 18, 2023

T.ONC

RE:RE:AA and mBC

Thx Noteable.   Would we not expect that ONCY would have more...

June 18, 2023

T.ONC

AA and mBC

If I recall correctly, paxlitaxol is now generic, or at least under a...

June 18, 2023

T.ONC

RE:RE:RE:RE:RE:Trodelvy improved PFS by 34% in heavily pre-treated patients

And already Trodelvy is now marketed and heralded in the NYT as part of the...

June 18, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:ONCY's pelareorep is now Phase 3-ready

Let us hope for peace and cooperation on this thread, and among all those...

June 18, 2023

T.ONC

Lengthy essay in NYT: Revolution in Cancer Treatment

https://www.nytimes.com/2023/06/16/opinion/cancer-treatment-disparities.html...

June 18, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Roche CD47 antibody start-up gives up-lays off all employees

The results that were announced last fall and then this June are more than...

June 18, 2023

T.ONC

RE:RE:RE:Trodelvy improved PFS by 34% in heavily pre-treated patients

Noteable, here is a question. Trodelvy was approved on its 12 month pfs. How...

June 18, 2023

T.ONC

RE:Future Value

Venture, ONCY's price languishes for complex and long standing reasons...

June 18, 2023

T.ONC

RE:RE:RE:RE:RE:RE:ONCY's pelareorep is now Phase 3-ready

Thanks everyone, for the encouraging comments and information. Some company...

June 17, 2023

T.ONC

RE:RE:Merck USA (MSD) acquires Phase 2 biotech for US$ 10.8 Bln.

Noteable's comment about this article is NOT hype for ONCY. It is the...

June 16, 2023

T.ONC

RE:RE:RE:RE:Anatomy of a Flagship Asset: Oncolytics Biotech

I agree Fox. Pehraps money is the bank is strength in negotiations. In fact,...

June 15, 2023

T.ONC

RE:Bloomberg Portfolio Manager sees small company acquisitions

Thanks, Noteable. And NO, this piece from bloomberg was NOT paid for by ONCY...

June 15, 2023

T.ONC

Highly impressive article on pela's effects

This article was published in 2021 about pela's ability to prime prostate...

June 15, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

Fox, In corporate mergers or takeovers, or in finance in general, creating a...

June 14, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncology

Fox, My theory, or rather long term dream: some Big pharma buys on third of...

June 14, 2023

T.ONC

RE:Some numbers to chew on….Roche & onc

Thanks for the info on tecentriq, CF. Here are a few further points...

June 13, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Trodelvy improved PFS by 34% in heavily pre-treated patients

I thought the same thing, Noteable. If that story on Trodelvy is new, and...

June 12, 2023

T.ONC

Volume and price moving

Monday Jume 12 we have 4 times the average volume and a 16% price jump. ...

June 12, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Trodelvy improved PFS by 34% in heavily pre-treated patients

Moreover, Trodelvey is an ADC. While I know nothing about ADC's, my...

June 11, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Diagnostear Technologies Inc

Diagnostear Technologies Inc C.DTR

DiagnosTear is a leading ophthalmic company developing and commercializing disruptive diagnostic solutions for better ... view more »